Dr. Vanderlugt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2152 Walker Trail
Kalamazoo, MI 49009Phone+1 269-370-5180
Education & Training
Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1979 - 1981
Corewell Health – Grand Rapids/Michigan State UniversityInternship, Internal Medicine, 1978 - 1979
University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
MI State Medical License 1979 - 2021
Clinical Trials
- Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects Start of enrollment: 2011 Sep 01
- Study of CXA-10 in Healthy Volunteers Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 168 citationsConversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.Annabelle Santos Volgman, Peter A. Carberry, Bruce S. Stambler, William R. Lewis, George H. Dunn
Journal of the American College of Cardiology. 1998-05-01 - 66 citationsEfficacy of Ibutilide for Termination of Atrial Fibrillation and FlutterKenneth A. Ellenbogen, Henry F. Clemo, Bruce S. Stambler, Mark A. Wood, James T. VanderLugt
The American Journal of Cardiology. 1996-10-17 - 147 citationsEfficacy and Safety of Ibutilide Fumarate for the Conversion of Atrial Arrhythmias After Cardiac SurgeryJames T. VanderLugt, Thomas Mattioni, Stephen Denker, David F. Torchiana, Thomas S. Ahern
Circulation. 1999-07-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
